The Effect of Mandala Coloring on Students' Anxiety Level and Quality of Life

NCT06180343 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-01-30

No results posted yet for this study

Summary

Anxiety is a mood that focuses on the future, related to being prepared for possible upcoming negative events (fear, pain or danger), and unlike fear, its object is not determined or recognized, and it is exposed to uncertainty. Art therapy is used in the clinical and rehabilitation field as a useful tool for self-expression, healing and well-being. The close relationship between art, healing and well-being, and the therapeutic power of art has long been accepted all over the world.Many studies have been conducted in the literature examining the effect of mandala painting on reducing anxiety.This proposed project was planned to be carried out as a quasi-experimental study, based on the idea that mandala painting can reduce the level of anxiety in students and have a positive effect on the quality of life.

Conditions

Interventions

OTHER

Mandala

Participants will be asked to choose the pages they want from the 12 colored felt-tip pen paint sets and mandala coloring book given to each participant by the researcher, and color them in the colors they want, for 6 weeks, once a week, at any time of the day and for an average of 20-30 minutes each time. Participants will be asked to send a message before they start painting the mandala, and after the process, they will be asked to take a picture of the mandala they have painted and send it to the researcher. If the participants forget to color the mandala, a reminder message will be sent by the researcher twice a week.

Sponsors & Collaborators

  • Kırklareli University

    lead OTHER

Principal Investigators

  • AYCA SOLT KIRCA, Phd · Kırklareli University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2024-03-15
Completion
2024-04-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180343 on ClinicalTrials.gov